Immunotherapy toxicity survey

UCLH cancer academy has been funded to develop multidisciplinary education on check point inhibitors and immune related adverse events.  We are very keen that the materials we produced are helpful to the whole BOPA membership.  To understand where the gaps are we have developed a questionnaire (see link below).  It will take less than 10 minutes to complete and will be really helpful for us to understand where the gaps are at different hospitals.  Please could this be completed by June 2nd.  If you have any questions or would like to keep in touch with our work, then please email Elly on [email protected].

https://forms.office.com/e/rAAj4DzjNK

Latest News

By Macmillan Cancer Support on 29th May 2026

Cancer Information Development team at Macmillan Cancer Support

Dear BOPA members, The Cancer Information Development team at Macmillan Cancer Support would like to make you aware of a couple of new cancer treatment information pages on our website:…

Read article
By BOPA Research Subcommittee on 25th May 2026

4-Week Reminder: Abstract Submission for #BOPA2026

Abstract Submission for the 29th Annual BOPA Conference 2026 is now OPEN   4 Weeks left to submit your Abstract for the 29th Annual BOPA Conference 2026. Submit your work…

Read article
By BOPA E&T Subcommittee on 20th May 2026

SAVE THE DATE: BOPA Introduction to Cancer Course, London, September 2026

The popular Introduction to Cancer Course is coming to London in September 2026 The BOPA Introduction to Cancer Course 2026 WHEN: Thursday 17th & Friday 18th September 2026 WHERE: University College Hospital,…

Read article
By BOPA Executive Committee on 19th May 2026

Invitation to share views on polypharmacy during cancer care – patient and healthcare professional surveys (Macmillan Cancer Support and the Royal College of Pharmacy)

Dear colleagues, Macmillan Cancer Support and the Royal College of Pharmacy are inviting patients and healthcare professionals to complete a short anonymous survey about experiences of taking and managing medicines…

Read article